Clinical Trials for NovelMed Therapeutics

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NovelMed Therapeutics

Clinical Trials (8)

Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

PHASE2Not yet recruiting

12 participants

Started: Jun 30, 2026 · Completed: Sep 30, 2028

1 condition1 sponsor0 locations

Study of NM8074 in Patients with Dermatomyositis (DM)

PHASE2Not yet recruiting

Started: Jun 30, 2026 · Completed: Dec 31, 2028

1 condition1 sponsor0 locations

Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

PHASE2Not yet recruiting

Started: Jun 30, 2026 · Completed: Mar 31, 2028

1 condition1 sponsor0 locations

Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

PHASE2Not yet recruiting

12 participants

Started: Apr 30, 2026 · Completed: Sep 30, 2028

1 condition1 sponsor0 locations

Study of NM8074 in Adult PNH Patients with Inadequate Response to Soliris

PHASE2Not yet recruiting

12 participants

Started: Jan 31, 2026 · Completed: Jan 31, 2028

1 condition1 sponsor0 locations

Study of NM8074 in Adult C3 Glomerulopathy Patients

PHASE1/PHASE2Not yet recruiting

18 participants

Started: Nov 30, 2025 · Completed: Jul 31, 2027

1 condition1 sponsor0 locations

Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)

PHASE2Not yet recruiting

10 participants

Started: Nov 30, 2025 · Completed: Jul 31, 2027

1 condition1 sponsor0 locations

Study of NM8074 in Patients with AHUS with Evidence of Ongoing Thrombotic Microangiopathy

PHASE2Not yet recruiting

12 participants

Started: Jul 31, 2025 · Completed: Feb 28, 2027

1 condition1 sponsor0 locations